LH vs LPCN · P/E 23, rev $13.95B vs rev $309.5K
Laboratory Corporation of America Holdings (LH) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
LH currently screens at market cap $21.07B and trailing P/E 22.8. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the LH and LPCN stock pages for the full models.
Not investment advice.